Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Large Scale Biology Corp.

www.lsbc.com

Latest From Guangzhou Bioseal Biotechnology Co. Ltd.

Asia On The Move: J&J Enhances China Business With New Chairman, Takeda Names First CFO

Jesse Wu, an advocate of a disciplined approach and allocating resources to growth markets like China, has been named J&J’s new China chairman. Takeda is aiming to integrate its global financial functions by adding a new CFO position, and a Takeda Asia R&D executive leaves for Sanofi.

BioPharmaceutical China

Charting Emerging Markets: J&J Growth Rates

PharmAsia News takes a closer look at J&J’s growth in key emerging markets.

BioPharmaceutical Medical Device

Device Trends To Watch In 2013

The prospective medical device tax, the continuing decline of venture investing, pricing challenges, austerity measures in Europe, and other headwinds continued to push against the medtech industry in 2012. But emerging clinical and geographic markets, along with an active M&A market, are providing the industry with some momentum going into 2013.

Medical Device Business Strategies

China Device Market May Gain As Reforms Favor Diagnostics And Prevention

China’s medical device market is posed to overtake France as the third largest by 2020 and pull even domestically with pharmaceuticals in coming years as government health care reforms put emphasis on diagnostics and prevention.

Medical Device China
See All

Company Information

  • Industry
  • Biotechnology
    • Synthesis Technologies, Production Processes
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Biosource Technology
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Large Scale Biology Corp.
  • Senior Management
  • Ronald Artale, SVP, CFO
    Guy della Cioppa, PhD, SVP, Bus. Dev.
    Kevin J Ryan, Pres.
    Gary Wolfe, PhD, SVP, CSO
  • Contact Info
  • Large Scale Biology Corp.
    Phone: (707) 446-5501
    3333 Vaca Valley Pkwy.
    Ste. 1000
    Vacaville, CA 95688
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register